Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)
Dr. Joseph Kim discusses with Equities.com discuses the potential of synthetic vaccines and immune therapies for cancers and infectious diseases.
This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
- Equities.com sits down with Manish...
- Published on 26 May 2013
- Views (535)
- Jeff Wolf of Heat Biologics sits down...
- Published on 02 October 2013
- Views (421)
- Market Leader Inc's (LEDR) Jacqueline...
- Published on 08 November 2011
- Views (436)
- Don Robinson of Eastmain Resources...
- Published on 28 May 2013
- Views (553)